Dear Members, Certara will be holding 2 courses for beginner and intermediate PK/PD Modeling scientists in Montreal, Canada. Register early and receive a 20% discount OR register for both classes and receive a 30% discount! (Discounts cannot be combined)
Interested in a custom on-site training course? Click here to view the benefits of on-site training and to request a proposal. http://info.certara.com/contact-us-for-custom-on-site-training Introduction to the Design, Role and Utility of PK/PD in Drug Development April 21-23, 2015 Montreal, Quebec, Canada Registration link: https://www.certara.com/training/classes/87 This introductory workshop provides an opportunity for drug development scientists to develop an understanding of basic pharmacokinetic and pharmacodynamic concepts and the role they play in efficient drug discovery and development. (early registration discount expires Feb 21, 2015) A unique feature of the course is the access to the computer package Phoenix WinNonlin to undertake hands-on exercises on real-life case studies and the availability of course tutors to help in problem solving. Intermediate PK/PD Modeling using Phoenix WinNonlin July 13-16 2015 Montreal, Quebec, Canada Registration link: https://www.certara.com/training/classes/89 This workshop is meant to bridge the gap between concepts of pharmacokinetic and pharmacodynamic models and their application to experimental data. (early registration discount expires May 13, 2015) Prerequisites: Participants should have a good background in pharmacokinetics and prior experience with Phoenix WinNonlin is highly recommended. Who Should Attend: Scientists in the pharmaceutical industry, regulatory agencies, contract research firms, universities, and for others who want to learn the statistical aspects of modeling. Andre Keller Marketing Campaign Manager Certara(tm) 5520 Dillard Dr., Suite 260 Cary, NC 27518 Tel +1-919-852-4611 www.certara.com<http://www.certara.com/> NOTICE: The information contained in this electronic mail message is intended only for the personal and confidential use of the designated recipient(s) named above. This message may be an attorney-client communication, may be protected by the work product doctrine, and may be subject to a protective order. As such, this message is privileged and confidential. If the reader of this message is not the intended recipient or an agent responsible for delivering it to the intended recipient, you are hereby notified that you have received this message in error and that any review, dissemination, distribution, or copying of this message is strictly prohibited. If you have received this communication in error, please notify us immediately by telephone and e-mail and destroy any and all copies of this message in your possession (whether hard copies or electronically stored copies). Thank you. buSp9xeMeKEbrUze
